{"analytics_identifier":null,"base_path":"/government/news/new-restrictions-on-parallel-exports-to-tackle-hrt-shortages","content_id":"e93fb80c-c10c-40aa-b9f5-560e1af883fc","document_type":"news_story","first_published_at":"2019-10-02T23:30:01.000+00:00","locale":"en","phase":"live","public_updated_at":"2019-10-03T08:54:13.000+00:00","publishing_app":"content-publisher","publishing_scheduled_at":null,"rendering_app":"government-frontend","scheduled_publishing_delay_seconds":null,"schema_name":"news_article","title":"New restrictions on parallel exports to tackle HRT shortages","updated_at":"2019-10-03T08:54:13.988Z","withdrawn_notice":{},"publishing_request_id":"14003-1570092853.520-10.3.3.1-1746","links":{"taxons":[{"api_path":"/api/content/health-and-social-care/medicines-medical-devices-blood-manufacturing-wholesaling-importing-exporting-medicines","base_path":"/health-and-social-care/medicines-medical-devices-blood-manufacturing-wholesaling-importing-exporting-medicines","content_id":"f441e630-2bba-4bbd-8c1b-22ae61cc00c2","document_type":"taxon","locale":"en","public_updated_at":"2018-08-22T12:56:20Z","schema_name":"taxon","title":"Manufacturing, wholesaling, importing and exporting medicines","withdrawn":false,"details":{"internal_name":"Manufacturing, wholesaling, importing and exporting medicines [T]","notes_for_editors":"","visible_to_departmental_editors":false},"phase":"live","links":{"parent_taxons":[{"api_path":"/api/content/health-and-social-care/medicines-medical-devices-blood","base_path":"/health-and-social-care/medicines-medical-devices-blood","content_id":"cebc01ee-f70a-4397-a552-622e10b62508","document_type":"taxon","locale":"en","public_updated_at":"2019-02-06T16:16:55Z","schema_name":"taxon","title":"Medicines, medical devices","withdrawn":false,"description":"","details":{"internal_name":"Medicines and medical devices [T] (level 2, health theme)","notes_for_editors":"","visible_to_departmental_editors":false},"phase":"live","links":{"parent_taxons":[{"api_path":"/api/content/health-and-social-care","base_path":"/health-and-social-care","content_id":"8124ead8-8ebc-4faf-88ad-dd5cbcc92ba8","document_type":"taxon","locale":"en","public_updated_at":"2018-09-16T20:30:51Z","schema_name":"taxon","title":"Health and social care","withdrawn":false,"description":"","details":{"internal_name":"Health and social care","notes_for_editors":"","visible_to_departmental_editors":true},"phase":"live","links":{"root_taxon":[{"api_path":"/api/content/","base_path":"/","content_id":"f3bbdec2-0e62-4520-a7fd-6ffd5d36e03a","document_type":"homepage","locale":"en","public_updated_at":"2019-06-21T11:52:37Z","schema_name":"homepage","title":"GOV.UK homepage","withdrawn":false,"links":{},"api_url":"https://www.gov.uk/api/content/","web_url":"https://www.gov.uk/"}]},"api_url":"https://www.gov.uk/api/content/health-and-social-care","web_url":"https://www.gov.uk/health-and-social-care"}]},"api_url":"https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood","web_url":"https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood"}]},"api_url":"https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood-manufacturing-wholesaling-importing-exporting-medicines","web_url":"https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood-manufacturing-wholesaling-importing-exporting-medicines"}],"topics":[{"api_path":"/api/content/topic/medicines-medical-devices-blood/manufacturing-wholesaling-importing-exporting-medicines","base_path":"/topic/medicines-medical-devices-blood/manufacturing-wholesaling-importing-exporting-medicines","content_id":"d6a1803f-e182-4ac2-978d-1fb07887ebb6","document_type":"topic","locale":"en","public_updated_at":"2018-10-26T10:47:10Z","schema_name":"topic","title":"Manufacturing, wholesaling, importing and exporting medicines","withdrawn":false,"links":{},"api_url":"https://www.gov.uk/api/content/topic/medicines-medical-devices-blood/manufacturing-wholesaling-importing-exporting-medicines","web_url":"https://www.gov.uk/topic/medicines-medical-devices-blood/manufacturing-wholesaling-importing-exporting-medicines"}],"organisations":[{"analytics_identifier":"D12","api_path":"/api/content/government/organisations/department-of-health-and-social-care","base_path":"/government/organisations/department-of-health-and-social-care","content_id":"7cd6bf12-bbe9-4118-8523-f927b0442156","document_type":"organisation","locale":"en","schema_name":"organisation","title":"Department of Health and Social Care","withdrawn":false,"details":{"logo":{"formatted_title":"Department\u003cbr/\u003eof Health \u0026amp;\u003cbr/\u003eSocial Care","crest":"single-identity"},"brand":"department-of-health","default_news_image":{"url":"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/default_news_organisation_image_data/file/235/s300_Default_image_39_Victoria_street_department_of_health.jpg","high_resolution_url":"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/default_news_organisation_image_data/file/235/s960_Default_image_39_Victoria_street_department_of_health.jpg"}},"links":{},"api_url":"https://www.gov.uk/api/content/government/organisations/department-of-health-and-social-care","web_url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"primary_publishing_organisation":[{"analytics_identifier":"D12","api_path":"/api/content/government/organisations/department-of-health-and-social-care","base_path":"/government/organisations/department-of-health-and-social-care","content_id":"7cd6bf12-bbe9-4118-8523-f927b0442156","document_type":"organisation","locale":"en","schema_name":"organisation","title":"Department of Health and Social Care","withdrawn":false,"details":{"logo":{"formatted_title":"Department\u003cbr/\u003eof Health \u0026amp;\u003cbr/\u003eSocial Care","crest":"single-identity"},"brand":"department-of-health","default_news_image":{"url":"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/default_news_organisation_image_data/file/235/s300_Default_image_39_Victoria_street_department_of_health.jpg","high_resolution_url":"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/default_news_organisation_image_data/file/235/s960_Default_image_39_Victoria_street_department_of_health.jpg"}},"links":{},"api_url":"https://www.gov.uk/api/content/government/organisations/department-of-health-and-social-care","web_url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"available_translations":[{"title":"New restrictions on parallel exports to tackle HRT shortages","public_updated_at":"2019-10-03T08:54:13Z","document_type":"news_story","schema_name":"news_article","base_path":"/government/news/new-restrictions-on-parallel-exports-to-tackle-hrt-shortages","api_path":"/api/content/government/news/new-restrictions-on-parallel-exports-to-tackle-hrt-shortages","withdrawn":false,"content_id":"e93fb80c-c10c-40aa-b9f5-560e1af883fc","locale":"en","api_url":"https://www.gov.uk/api/content/government/news/new-restrictions-on-parallel-exports-to-tackle-hrt-shortages","web_url":"https://www.gov.uk/government/news/new-restrictions-on-parallel-exports-to-tackle-hrt-shortages","links":{}}]},"description":"There will be new restrictions on exporting hormone replacement therapy (HRT) products, which currently face supply shortages due to manufacturing issues.","details":{"body":"\u003cp\u003eThe government has confirmed new restrictions on the export of all variations of \u003cabbr title=\"hormone replacement therapy\"\u003eHRT\u003c/abbr\u003e products, some of which currently face supply shortages due to manufacturing issues.\u003c/p\u003e\n\n\u003cp\u003eThe restrictions will stop some medicine wholesalers from ‘parallel exporting’. This is when companies buy medicines meant for UK patients and sell them on for a higher price in another country, potentially causing supply problems.\u003c/p\u003e\n\n\u003cp\u003eAround 360,000 prescriptions of \u003cabbr title=\"hormone replacement therapy\"\u003eHRT\u003c/abbr\u003e are dispensed a month to relieve symptoms of the menopause. Currently, some \u003cabbr title=\"hormone replacement therapy\"\u003eHRT\u003c/abbr\u003e drugs are being parallel exported. The new restrictions will end this practice to ensure people can still access the medicines they need.\u003c/p\u003e\n\n\u003cp\u003eNineteen \u003cabbr title=\"hormone replacement therapy\"\u003eHRT\u003c/abbr\u003e drugs will be subject to export restrictions to ensure that alternatives remain available for the \u003cabbr title=\"hormone replacement therapy\"\u003eHRT\u003c/abbr\u003e drugs that are in short supply. Similar measures are in place in other European countries, including France and Spain.\u003c/p\u003e\n\n\u003cp\u003eNew restrictions for a further 5 medicines, including all adrenaline auto-injectors and hepatitis B vaccines, have also come into force to protect supplies of these products for patients.\u003c/p\u003e\n\n\u003cp\u003e\u003ca href=\"https://www.gov.uk/government/publications/medicines-that-cannot-be-parallel-exported-from-the-uk\"\u003eA full list of the medicines that cannot be parallel exported from the UK has been published.\u003c/a\u003e\u003c/p\u003e\n\n\u003cp\u003eThe Department of Health and Social Care (DHSC) has been working closely with affected suppliers to monitor the situation and reduce the potential impact on patients. The new measures will further reduce the impact on patients.\u003c/p\u003e\n\n\u003cp\u003eDHSC has written to holders of wholesale dealer licences to tell them that the government will exercise its powers to stop parallel exporting of medicines that are needed for UK patients. \u003c/p\u003e\n\n\u003csection class=\"gem-c-attachment\"\u003e\n  \u003cdiv class=\"gem-c-attachment__thumbnail\"\u003e\n    \u003ca class=\"govuk-link\" target=\"_self\" tabindex=\"-1\" aria-hidden=\"true\" href=\"https://assets.publishing.service.gov.uk/media/5d95b627ed915d08f0f326a8/letter-to-wda-holders.pdf\"\u003e\n        \u003csvg class=\"gem-c-attachment__thumbnail-image\" version=\"1.1\" viewbox=\"0 0 99 140\" width=\"99\" height=\"140\" aria-hidden=\"true\"\u003e\n  \u003cpath d=\"M12 12h75v27H12zM12 59h9v9h-9zM12 77h9v9h-9zM12 95h9v9h-9zM12 113h9v9h-9zM30 59h57v9H30zM30 77h39v9H30zM30 95h57v9H30zM30 113h48v9H30z\" stroke-width=\"0\"\u003e\u003c/path\u003e\n\u003c/svg\u003e\n\n\u003c/a\u003e\n\u003c/div\u003e\n  \u003cdiv class=\"gem-c-attachment__details\"\u003e\n    \u003ch2 class=\"gem-c-attachment__title\"\u003e\n      \u003ca class=\"govuk-link gem-c-attachment__link\" target=\"_self\" href=\"https://assets.publishing.service.gov.uk/media/5d95b627ed915d08f0f326a8/letter-to-wda-holders.pdf\"\u003eLetter to holders of a wholesale dealer licence\u003c/a\u003e\n\u003c/h2\u003e\n      \u003cp class=\"gem-c-attachment__metadata\"\u003e\u003cspan class=\"gem-c-attachment__attribute\"\u003e\u003cabbr title=\"Portable Document Format\" class=\"gem-c-attachment__abbr\"\u003ePDF\u003c/abbr\u003e\u003c/span\u003e, \u003cspan class=\"gem-c-attachment__attribute\"\u003e51.3 KB\u003c/span\u003e, \u003cspan class=\"gem-c-attachment__attribute\"\u003e3 pages\u003c/span\u003e\u003c/p\u003e\n\n\n      \u003cp class=\"gem-c-attachment__metadata\"\u003eThis file may not be suitable for users of assistive technology.\u003c/p\u003e\n      \u003cdetails class=\"gem-c-details govuk-details govuk-!-margin-bottom-3\" data-module=\"govuk-details\"\u003e\n  \u003csummary class=\"govuk-details__summary\"\u003e\n    \u003cspan class=\"govuk-details__summary-text\"\u003e\n      Request a different format\n    \u003c/span\u003e\n  \u003c/summary\u003e\n  \u003cdiv class=\"govuk-details__text\"\u003e\n    \n        If you use assistive technology and need a version of this document in a more accessible format, please email \u003ca href=\"mailto:publications@dhsc.gov.uk\" target=\"_blank\" class=\"govuk-link\"\u003epublications@dhsc.gov.uk\u003c/a\u003e. Please tell us what format you need. It will help us if you say what assistive technology you use.\n\n  \u003c/div\u003e\n\u003c/details\u003e\n\u003c/div\u003e\u003c/section\u003e\n\n\u003cp\u003eCompanies that parallel export a medicine that is on the list may face action from the Medicines and Healthcare products Regulatory Agency (MHRA).\u003c/p\u003e\n\n\u003cp\u003eThe government has also introduced serious shortage protocols for the antidepressant fluoxetine, to further protect UK patients from medicine shortages. This means pharmacists can supply an alternative strength or pharmaceutical form of fluoxetine when patients have a prescription for the 10mg, 30mg and 40mg capsules, which are currently in shortage.\u003c/p\u003e\n\n\u003cp\u003eThe serious shortage protocol will be in place while manufacturing issues mean the drug is temporarily in short supply, to ease pressure on the supply chain.\u003c/p\u003e\n\n\u003cp\u003eSerious shortage protocols are drawn up with senior, specialist doctors and pharmacists and are approved by national experts, including the Chief Pharmaceutical Officer and the National Medical Director at NHS England.\u003c/p\u003e\n\n\u003cp\u003eMedicine shortages do occasionally occur in the UK. DHSC has existing, well-established processes to deal with and resolve shortages. The new parallel export restrictions and serious shortage protocol will support this approach.\u003c/p\u003e\n\n\u003cp\u003eThe medicine supply chain is complex and highly regulated, so problems can arise for a variety of reasons, including manufacturing issues or problems with raw ingredients. \u003c/p\u003e\n\n\u003cp\u003eHealth and Social Care Secretary Matt Hancock said:\u003c/p\u003e\n\n\u003cblockquote\u003e\n  \u003cp\u003eI know how distressing medicine shortages can be for those who rely on drugs like \u003cabbr title=\"hormone replacement therapy\"\u003eHRT\u003c/abbr\u003e and it’s absolutely crucial patients can always access safe and effective treatments through the NHS.\u003c/p\u003e\n\n  \u003cp\u003eThe new measures we’re introducing today will help us ensure patients get the medicines they need and the high-quality care they deserve.\u003c/p\u003e\n\n  \u003cp class=\"last-child\"\u003eHelping the NHS is a priority for this government, and people should be fully reassured that we will always act to ensure that there is an adequate supply of the medicine you need.\u003c/p\u003e\n\u003c/blockquote\u003e\n\n\u003cp\u003eDr Rick Greville, Director of Supply Chain at the Association of the British Pharmaceutical Industry, said:\u003c/p\u003e\n\n\u003cblockquote\u003e\n  \u003cp\u003eThe decision to take precautionary measures to protect medicines supplies will be very much welcomed by our members.\u003c/p\u003e\n\n  \u003cp\u003eIt means that these stockpiles of medicines which companies have built over previous months are better protected and available for use only by the NHS patients for which they were intended.\u003c/p\u003e\n\n  \u003cp class=\"last-child\"\u003eCompanies can now work with the department to identify any problem areas.\u003c/p\u003e\n\u003c/blockquote\u003e\n\n","image":{"high_resolution_url":"https://assets.publishing.service.gov.uk/media/5d94c25ded915d553b43aa2b/hrt.jpg","url":"https://assets.publishing.service.gov.uk/media/5d94c25b40f0b6422b422b35/hrt.jpg","alt_text":"HRT medication","caption":"","credit":""},"change_history":[{"note":"First published.","public_timestamp":"2019-10-02T15:38:43.544Z"},{"note":"Attached letter to holders of wholesale dealer licenses.","public_timestamp":"2019-10-03T08:50:55.327Z"}]}}